Savant Capital’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.57M | Buy |
8,228
+3,639
| +79% | +$669K | ﹤0.01% | 690 |
|
|
2026
Q1 | $866K | Buy |
4,589
+743
| +19% | +$157K | ﹤0.01% | 675 |
|
|
2025
Q4 | $764K | Buy |
3,846
+28
| +0.7% | +$5.66K | ﹤0.01% | 666 |
|
|
2025
Q3 | $775K | Buy |
3,818
+4
| +0.1% | +$710 | ﹤0.01% | 648 |
|
|
2025
Q2 | $671K | Sell |
3,814
-146
| -4% | -$22K | ﹤0.01% | 643 |
|
|
2025
Q1 | $533K | Sell |
3,960
-3,479
| -47% | -$458K | ﹤0.01% | 656 |
|
|
2024
Q4 | $939K | Buy |
7,439
+699
| +10% | +$104K | 0.01% | 676 |
|
|
2024
Q3 | $1.12M | Sell |
6,740
-782
| -10% | -$118K | 0.01% | 603 |
|
|
2024
Q2 | $1M | Buy |
7,522
+2,979
| +66% | +$359K | 0.01% | 588 |
|
|
2024
Q1 | $478K | Buy |
4,543
+1,024
| +29% | +$92K | 0.01% | 740 |
|
|
2023
Q4 | $266K | Sell |
3,519
-65
| -2% | -$4.12K | ﹤0.01% | 735 |
|
|
2023
Q3 | $236K | Buy |
3,584
+153
| +4% | +$11.4K | ﹤0.01% | 718 |
|
|
2023
Q2 | $279K | Buy |
+3,431
| New | +$244K | ﹤0.01% | 664 |
|
|
2022
Q3 | – | Sell |
-4,277
| Closed | -$225K | – | 576 |
|
|
2022
Q2 | $225K | Sell |
4,277
-508
| -11% | -$35.4K | 0.01% | 503 |
|
|
2022
Q1 | $411K | Buy |
4,785
+161
| +3% | +$13.2K | 0.01% | 388 |
|
|
2021
Q4 | $378K | Buy |
4,624
+263
| +6% | +$19.2K | 0.01% | 407 |
|
|
2021
Q3 | $290K | Buy |
4,361
+38
| +0.9% | +$2.69K | 0.01% | 431 |
|
|
2021
Q2 | $290K | Buy |
4,323
+303
| +8% | +$18.8K | 0.01% | 409 |
|
|
2021
Q1 | $209K | Buy |
+4,020
| New | +$203K | 0.01% | 440 |
|
|
2016
Q3 | – | Sell |
-8,060
| Closed | -$223K | – | 255 |
|
|
2016
Q2 | $223K | Sell |
8,060
-570
| -7% | -$16.8K | 0.06% | 224 |
|
|
2016
Q1 | $250K | Buy |
8,630
+340
| +4% | +$8.85K | 0.08% | 193 |
|
|
2015
Q4 | $251K | Sell |
8,290
-360
| -4% | -$11.8K | 0.08% | 194 |
|
|
2015
Q3 | $319K | Hold |
8,650
| – | – | 0.11% | 149 |
|
|
2015
Q2 | $501K | Sell |
8,650
-10
| -0.1% | -$511 | 0.17% | 103 |
|
|
2015
Q1 | $429K | Buy |
8,660
+30
| +0.3% | +$1.4K | 0.15% | 116 |
|
|
2014
Q4 | $437K | Sell |
8,630
-70
| -0.8% | -$3.66K | 0.17% | 106 |
|
|
2014
Q3 | $517K | Sell |
8,700
-20
| -0.2% | -$1.12K | 0.22% | 82 |
|
|
2014
Q2 | $409K | Sell |
8,720
-102
| -1% | -$4.61K | 0.18% | 98 |
|
|
2014
Q1 | $378K | Buy |
+8,822
| New | +$389K | 0.18% | 102 |
|
Other funds holding THC
GCM
Savant Capital's THC Position: Q2 2026 in Review
Savant Capital increased its Tenet Healthcare (THC) stake by 79% in Q2 2026, buying an estimated $669K and bringing the position to 8,228 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #690.
Savant Capital first reported a position in THC in Q1 2014 and has held it in 29 quarters since. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.
- Savant Capital held 8,228 shares of Tenet Healthcare worth $1.57M as of Q2 2026.
- Savant Capital bought 3,639 Tenet Healthcare shares in Q2 2026, an estimated $669K.
- Tenet Healthcare made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #690 holding.
- Savant Capital first reported a position in Tenet Healthcare in Q1 2014 and has held it in 29 quarters since.
- 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.
Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.